News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets largely unchanged as no economic data or corporate news surfaced this hour.
  • U.S. Treasury yields stayed stable with no fresh fiscal or inflation signals.
  • Oil and commodities traded in narrow ranges after a quiet hour and no supply updates.
  • No geopolitical developments reported, leaving risk sentiment unchanged.
  • No central bank or government policy moves announced during the hour.
  • Corporate news flow was nil with no earnings, M&A, or guidance changes reported.

Latest Articles

Deutsche Bank Sees Euro Holding Its Trading Band Despite Dollar Strength

Deutsche Bank Sees Euro Holding Its Trading Band Despite Dollar Strength

Deutsche Bank expects the euro to remain within this year’s 1.13-1.20 EUR/USD trading range and keeps a 1.17 year-end forecast. The bank points to resilient global growth led by capital spending in AI and strategic autonomy, signs of economic strength in several regions, a completed view of Fed terminal pricing and a market that appears to be prici…

NCL Corporation Ltd. Announces Proposed Offering of Senior Notes

NCL Corporation Ltd. Announces Proposed Offering of Senior Notes

NCL Corporation Ltd., a subsidiary of Norwegian Cruise Line Holdings Ltd., announced a proposed private offering of $750 million senior notes due 2031. The proceeds will be used to redeem outstanding 2028 senior notes, repay borrowings under their revolving loan facility, and prepay export-credit financed debt. This refinancing aims to optimize the…

DXP Enterprises: 12.2% Adjusted EBITDA Case Strengthens Rerating Trade

DXP Enterprises: 12.2% Adjusted EBITDA Case Strengthens Rerating Trade

DXP Enterprises (DXPE) is showing the mix and margin characteristics that can support a permanent move higher in valuation. With a market cap near $2.83B, EV/EBITDA about 16x and free cash flow of $118.7M, a sustainable ~12.2% adjusted EBITDA margin would justify a meaningful rerate. This trade idea outlines a clear entry, stop and target with a 18…

PRA Group: Cheap to Book, Priced for Pain — A Tactically Timed Long

PRA Group: Cheap to Book, Priced for Pain — A Tactically Timed Long

PRA Group (PRAA) trades at roughly 0.7x book and 0.55x price-to-sales while continuing to generate resilient cash collections from purchased nonperforming loan (NPL) portfolios. The balance sheet is levered and free cash flow is negative today, which explains the discount, but the mismatch between equity value ($732m market cap) and implied book (~…

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

Wave Life Sciences announced that GSK has selected a hepatology siRNA candidate developed using Wave's proprietary SpiNA design for further development in GSK's pipeline. This milestone triggers a $12 million payment to Wave, with potential for substantially more through future milestones and royalties. The collaboration includes three other progra…

Green Circle Decarbonize Technology Limited Submits Tender Proposals for Chiller Replacement Engineering at MOS Centre and Air-Conditioning Retrofit & Operation and Maintenance at Nan Fung Centre in Hong Kong

Green Circle Decarbonize Technology Limited Submits Tender Proposals for Chiller Replacement Engineering at MOS Centre and Air-Conditioning Retrofit & Operation and Maintenance at Nan Fung Centre in Hong Kong

Green Circle Decarbonize Technology Limited, through its subsidiary Boca International Limited, has submitted two tender proposals worth a combined HKD 67 million for engineering projects involving chiller replacement and air-conditioning retrofit in key Hong Kong commercial centers. These projects emphasize energy efficiency, carbon emission reduc…

Atlantic HPC Group Inc Acquires Valley Oasis Development LLC, Adding 29 MW of Contracted Power to Platform

Atlantic HPC Group Inc Acquires Valley Oasis Development LLC, Adding 29 MW of Contracted Power to Platform

Atlantic HPC Group Inc has acquired Valley Oasis Development LLC, a Tennessee-based entity holding contracts for 29 MW of utility power and a strategically located land lease suitable for bitcoin mining and AI compute deployments. This acquisition increases Atlantic's total utility-approved capacity to 127 MW across multiple states, strengthening i…

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Arbutus Biopharma Corporation has revealed preliminary results of its $230 million modified Dutch auction tender offer to repurchase up to 46 million shares at $5.00 per share. The tender offer was oversubscribed, leading to proration of shares purchased at about 55% for auction tenders at or below the purchase price. Roivant Sciences, a major shar…

Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cytokinetics announced the initiation of ASPEN-HCM, a prospective, multi-center real-world study assessing the safety, clinical effectiveness, and healthcare resource impact of MYQORZO (aficamten) in adult patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). The study is led by UCSF and plans to enroll approximately 400 patient…

DT Midstream Publishes Annual Sustainability Report

DT Midstream Publishes Annual Sustainability Report

DT Midstream, a natural gas infrastructure company listed on the NYSE under ticker DTM, published its annual Corporate Sustainability Report detailing the company’s environmental, social, and governance accomplishments. The report emphasizes DT Midstream's commitment to sustainable operations and its role in safely delivering natural gas to key US …

Oregon Department of Transportation Selects Rekor Command® to Deliver Safety Alerts Directly to Drivers Statewide

Oregon Department of Transportation Selects Rekor Command® to Deliver Safety Alerts Directly to Drivers Statewide

Rekor Systems announced that the Oregon Department of Transportation intends to award them a $1.4 million contract over five years to implement their Connected In-Vehicle Alerts program statewide. This program will bring timely roadway safety alerts directly to drivers via vehicle displays and navigation apps, building on Rekor's successful deploym…

Buy Sezzle on This Pullback - Mid-Term Trade Plan

Buy Sezzle on This Pullback - Mid-Term Trade Plan

Sezzle's latest quarter showed 51.7% revenue growth, 76% subscriber expansion and improving profitability. Price weakness in September has created a defined risk entry with upside to $145 if growth and merchant expansion continue. This trade targets a mid-term rebound over 45 trading days with tight risk control.

Coinbase: Ride the Bitcoin Breakout — Tactical Long on COIN (Swing)

Coinbase: Ride the Bitcoin Breakout — Tactical Long on COIN (Swing)

Coinbase looks well positioned to benefit from a renewed Bitcoin breakout and expanding institutional stablecoin partnerships. Valuation is rich on price-to-sales but supported by strong free cash flow and an enterprise value near $48B. This trade idea sets a clear entry at $192.25, stop at $170.00 and a $260.00 target on a mid-term swing (up to 45…

Molson Coors Looks Cheap—but Not Cheap Enough to Ignore the Risks

Molson Coors Looks Cheap—but Not Cheap Enough to Ignore the Risks

Molson Coors (TAP) trades at deeply discounted multiples and throws off strong free cash flow and a chunky dividend, yet it faces a secular beer-volume decline, material leverage and uneven recent results. This trade idea is a cautious, mid-term long that treats the stock as a value rebound candidate rather than a buy-and-forget income play.

Outbreaks and outages: Havana's water and power collapse fuels viral spread

Outbreaks and outages: Havana's water and power collapse fuels viral spread

Residents of Havana are confronting widespread power failures and prolonged water outages that have contributed to viral and diarrheal illnesses. The city's reliance on electric pumps and recent US-imposed fuel restrictions have intensified blackouts, impairing refrigeration and water distribution for millions. Health authorities in Cuba and a rece…

Ocugen to Participate in Upcoming Scientific Conferences

Ocugen to Participate in Upcoming Scientific Conferences

Ocugen, Inc. announced its participation in several upcoming scientific conferences where it will present its novel modifier gene therapy platform targeting blindness diseases such as geographic atrophy, Stargardt disease, and retinitis pigmentosa. The company aims to demonstrate progress from multiple clinical trials including Phase 1/2 and Phase …

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

Tiziana Life Sciences announced the submission of an Orphan Drug Designation request to the FDA for intranasal foralumab, an immunomodulatory therapy aimed at treating Multiple System Atrophy (MSA). This designation would provide regulatory benefits including market exclusivity and tax credits, supporting advancement of this novel treatment. The co…

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)

Rafael Holdings announced topline results from its pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C (NPC). While the primary endpoint did not reach statistical significance in the overall population, a prespecified subgroup receiving background miglustat and/or leucine therapy (83% of patients) showed …

Ambow Launches HybriU Events On Demand, Bringing AI-Powered Hybrid Events to Venues in a Single Transport Case

Ambow Launches HybriU Events On Demand, Bringing AI-Powered Hybrid Events to Venues in a Single Transport Case

Ambow Education Holding Ltd. (NYSE American: AMBO) has introduced HybriU Events On Demand, a portable, AI-driven hybrid event system delivered in a single transport case, enabling venues to host professional 2D/3D live broadcasts, real-time interpretation in 65+ languages, recording, and AI knowledge capture without permanent installation or equipm…

GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV Inc. announced the final results of its cash tender offer to repurchase up to $20 million of its ordinary shares at $11.03 per share. Only 57,110 shares (approximately 0.3% of total shares) were tendered and purchased, costing about $630,000. The repurchased shares will be held as treasury stock for potential future issuance. This buyback repr…

NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

NRx Pharmaceuticals' subsidiary, NRx Defense Systems, received an $11.18 million contract from DARPA to conduct the SPARC-TMS clinical trial evaluating a novel one-day robotic transcranial magnetic stimulation (TMS) protocol augmented with their investigational drug NRX-101 for treatment resistant depression. The trial, conducted at prestigious ins…